Article Text

Download PDFPDF
Recent trends in the epidemiology of sexually transmitted infections in the European Union
  1. K A Fenton1,2,
  2. C M Lowndes1,
  3. the European Surveillance of Sexually Transmitted Infections (ESSTI) Network*
  1. 1Department of HIV and Sexually Transmitted Infections, Health Protection Agency Communicable Disease Surveillance Centre, 61 Colindale Avenue, London NW9 5EQ, UK
  2. 2Centre for Sexual Health and HIV Research, Departments of Primary Care and Population Sciences, Royal Free and University College Medical School, Mortimer Market Centre, off Capper Street, London WC1E 6AU, UK
  1. Correspondence to:
 Dr Kevin A Fenton
 HIV/STI Department, Health Protection Agency, Communicable Disease Surveillance Centre, 61 Colindale Avenue, London NW9 5EQ, UK; kevin.fentonhpa.org.uk

Abstract

Sexually transmitted infections (STIs) are a major public health problem in Europe. We review recent trends in the epidemiology of the major acute STIs in the European Union and Norway, their key determinants, and opportunities for enhancing STI prevention interventions in the region.

  • CISID, WHO Computerized Information System for Infectious Diseases
  • EU, European Union
  • HPV, human papillomavirus
  • NAATs, nucleic acid amplification tests
  • PCR, polymerase chain reaction
  • STI, sexually transmitted infections
  • sexually transmitted diseases
  • Europe
  • epidemiology
  • surveillance

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • * The ESSTI Network: Members of ESSTI Collaborative and Steering Groups

    Austria: Reinhild Strauss, BM for Social Security and Generations, Vienna; Angelika Stary, Outpatient Center for Diagnosis of Infectious Venerodermatological Diseases, Vienna. Belgium: Andre Sasse, Epidemiology Section, Scientific Institute of Public Health, Brussels; Marjan Van Esbroeck, Institute of Tropical Medicine, Antwerp. Denmark: Else Smith, Department of Epidemiology, Statens Serum Institut, Copenhagen; Steen Hoffmann*, Department of Epidemiology, Statens Serum Institut, Copenhagen. Finland: Angela Rose, Department of Infectious Disease Epidemiology, National Public Health Institute (KTL), Helsinki; Pentti Huovinen, Antimicrobial Research Laboratory, National Public Health Institute, Turku. France: Veronique Goulet; Françoise Hamers*, Institut de Veille Sanitaire; Dépt des maladies infectieuses, St Maurice; Patrice Sednaoui, Laboratoire de Bactériologie, Institut Fournier, Paris. Germany: Osamah Hamouda, Infektionsepidemiologie/AIDS-Zentrum, Robert Koch Institut, Berlin; Peter Kohl, Department of Dermatology and Venereology, Neukolln Academic Hospital, Free University of Berlin. Greece: Mina Psichogiou, Hellenic Center for Infectious Diseases Control, Department for Surveillance and Intervention, Athens; Eva Tzelepi, National Reference Center for N gonorrhoeae, Hellenic Pasteur Institute, Athens. Ireland: Mary Cronin, National Disease Surveillance Centre, Dublin. Italy: Barbara Suligoi*, Laboratory of Epidemiology and Biostatistics, Istituto Superiore di Sanità, Rome; Paola Stefanelli, Dept of Infectious, Parasitic and Immuno-mediated Diseases, Istituto Superiore di Sanità, Rome. Netherlands: Marita van de Laar*, National Institute of Public Health and the Environment (RIVM), Department of Infectious Disease Epidemiology, Bilthoven; Joke Spaargaren, GG and GD Amsterdam, Public Health Laboratory, Amsterdam. Norway: Preben Aavitsland, Norwegian Institute of Public Health, Oslo; Jorgen Lassen, Norwegian Institute of Public Health, Oslo. Portugal: Jacinta Azevedo, Consulta de DST do Centro de Saude da Lapa, Lisbon; Maria Jose Borrego, Centro de Bacteriologia, Instituto Nacional de Saude Dr Ricardo Jorge, Lisbon. Spain: Jesús Castilla, Centro Nacional de Epidemiología, Instituto de Salud Carlos lll, Madrid; Julio Vazquez, Centro Nacional de Microbiologia, Madrid. Sweden: Torsten Berglund*, Swedish Institute for Infectious Disease Control, Solna; Johan Giesecke*, Swedish Institute for Infectious Disease Control, Solna; Hans Fredlund, Swedish Reference Laboratory for Pathogenic Neisseria, University Hospital, Örebro. UK: Mike Catchpole*, Health Protection Agency Communicable Disease Surveillance Centre, London; Hugh Young*, Scottish Neisseria gonorrhoeae Reference Laboratory (SNGRL), Laboratory Medicine (Microbiology), Edinburgh Royal Infirmary, Edinburgh; Chris Bartlett*, UCL Centre for Infectious Disease Epidemiology, Department of Primary Care and Population Sciences, London; Cathy Ison*, Department of Infectious Diseases and Microbiology, Imperial College School of Medicine, London; Jodi Cooper, Health Protection Agency Communicable Disease Surveillance Centre, London; Anne Scoular, Scottish Centre for infection and Environmental Health, Glasgow.

    Member of ESSTI Steering Group.